BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32502866)

  • 1. Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety.
    Soliman AM; Karam HM; Mekkawy MH; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Eur J Med Chem; 2020 Aug; 200():112467. PubMed ID: 32502866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress.
    Soliman AM; Mekkawy MH; Karam HM; Higgins M; Dinkova-Kostova AT; Ghorab MM
    Bioorg Med Chem Lett; 2021 Jun; 42():128002. PubMed ID: 33811990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway.
    Soliman AM; Karam HM; Mekkawy MH; Ghorab MM
    Eur J Med Chem; 2020 Jul; 197():112333. PubMed ID: 32361176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1.
    Ghorab MM; Alsaid MS; El-Gazzar MG; Higgins M; Dinkova-Kostova AT; Shahat AA
    J Enzyme Inhib Med Chem; 2016; 31(sup1):34-39. PubMed ID: 27033734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides.
    Ghorab MM; Higgins M; Alsaid MS; Arafa RK; Shahat AA; Dinkova-Kostova AT
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):840-5. PubMed ID: 24417210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives.
    Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
    Drug Des Devel Ther; 2016; 10():2515-24. PubMed ID: 27540279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors.
    Soliman AM; Ghorab WM; Lotfy DM; Karam HM; Ghorab MM; Ramadan LA
    Sci Rep; 2023 Sep; 13(1):15546. PubMed ID: 37730974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
    Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
    Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1.
    Dietz BM; Liu D; Hagos GK; Yao P; Schinkovitz A; Pro SM; Deng S; Farnsworth NR; Pauli GF; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2008 Oct; 21(10):1939-48. PubMed ID: 18808158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indigofera suffruticosa Mill extracts up-regulate the expression of the π class of glutathione S-transferase and NAD(P)H: quinone oxidoreductase 1 in rat Clone 9 liver cells.
    Chen CC; Liu CS; Li CC; Tsai CW; Yao HT; Liu TC; Chen HW; Chen PY; Wu YL; Lii CK; Liu KL
    Food Chem Toxicol; 2013 Sep; 59():610-7. PubMed ID: 23831193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening active components of modified Xiaoyao powder as NRF2 agonists.
    Yang Y; Wang Y; Wang T; Jiang X; Wang L
    Cell Biochem Funct; 2017 Dec; 35(8):518-526. PubMed ID: 29214656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
    Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
    Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress.
    Hu YR; Ma H; Zou ZY; He K; Xiao YB; Wang Y; Feng M; Ye XL; Li XG
    Biomed Pharmacother; 2017 Jan; 85():313-322. PubMed ID: 27903425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
    Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation.
    Aghagolzadeh P; Radpour R; Bachtler M; van Goor H; Smith ER; Lister A; Odermatt A; Feelisch M; Pasch A
    Atherosclerosis; 2017 Oct; 265():78-86. PubMed ID: 28865326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors.
    Nioi P; Hayes JD
    Mutat Res; 2004 Nov; 555(1-2):149-71. PubMed ID: 15476858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
    Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
    J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel 2-phenylquinazolin-4-amine derivatives.
    Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1612-8. PubMed ID: 27052554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    Kasai S; Arakawa N; Okubo A; Shigeeda W; Yasuhira S; Masuda T; Akasaka T; Shibazaki M; Maesawa C
    PLoS One; 2016; 11(4):e0153181. PubMed ID: 27045471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.